Immediate Impact
3 from Science/Nature 68 standout
Citing Papers
NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer
2023 Standout
Y chromosome loss in cancer drives growth by evasion of adaptive immunity
2023 StandoutNature
Works of Joseph Scattergood being referenced
Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Joseph Scattergood | 206 | 60 | 26 | 88 | 76 | 7 | 297 | |
| J.L.J. Vriesema | 263 | 38 | 37 | 70 | 42 | 12 | 333 | |
| Jordan Kardos | 124 | 75 | 18 | 104 | 77 | 11 | 243 | |
| Assaad M. Mounzer | 184 | 125 | 30 | 56 | 28 | 5 | 305 | |
| Sally Hanna | 247 | 70 | 32 | 36 | 80 | 9 | 298 | |
| Gudrun Schlake | 199 | 47 | 6 | 105 | 56 | 9 | 275 | |
| Gianfranco Mattarelli | 119 | 102 | 14 | 68 | 33 | 10 | 265 | |
| Felix M. Brown | 205 | 60 | 45 | 43 | 68 | 7 | 278 | |
| Dominga Elsa Velázquez | 138 | 17 | 54 | 84 | 103 | 12 | 303 | |
| Tae-Beom Kim | 123 | 35 | 11 | 76 | 44 | 5 | 187 | |
| Ester Simeone | 173 | 137 | 11 | 30 | 126 | 6 | 289 |
All Works
Loading papers...